US approval of Maxigesic bumps up AFT share price

+Print Archive
Business

US approval of Maxigesic bumps up AFT share price

Jonathan Chilton Towle 2019

Jonathan Chilton-Towle

Harley Atkinson AFT Pharmaceuticals
AFT managing director Hartley Atkinson says Maxigesic is a therapeutic option in the US opioid epidemic
The New Zealand sharemarket reacted positively to news that AFT Pharmaceuticals’ flagship product Maxigesic had been approved for sale in the US. A